Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Planned sale Director sold 10,960 shares at $12.52 ($137,219)
  2. 4 Open-market sale EVP and General Counsel sold 76 shares at $8.22 ($625)
  3. 4 Grant or award EVP & Chief Financial Officer acquired 75,000 shares (grant or award)
  4. 4 Planned sale EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
  5. 4 Planned sale EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
  6. 4 Other disposition Director disposed of 1,196,540 shares (other)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Director sold 12,190 shares at $7.80 ($95,032)
  11. 4 Grant or award EVP and Chief Medical Officer acquired 75,000 shares (grant or award)
  12. 4 Other disposition Chief Executive Officer disposed of 53,118 shares (other)
  13. 4 Open-market sale Director sold 4,000 shares at $10.95 ($43,789)
  14. 4 Grant or award Director acquired 8,000 shares (grant or award)
  15. 4 Grant or award Director acquired 8,000 shares (grant or award)
  16. 4 Grant or award Director acquired 8,000 shares (grant or award)
  17. 4 Grant or award Director acquired 8,000 shares (grant or award)
  18. 4 Grant or award Director acquired 8,000 shares (grant or award)
  19. 4 Grant or award Director acquired 8,000 shares (grant or award)
  20. 4 Grant or award Director acquired 8,000 shares (grant or award)

Page 5 of 25 · 491 filings